Regulator T Cells therapy(Xuzhou Medical University)

N/A

Report date: 2024/05/15 20:00:35

Base Information

Drug NameRegulator T Cells therapy(Xuzhou Medical University)

Drug Alias NameAutologous Regulatory T-Lymphocytes Cells therapy(Xuzhou Medical University)Treg Cell therapy(Xuzhou Medical University)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tregs

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsGraft vs Host Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesXuzhou Medical University (Xzmu)

China Registration ClassN/A

Develop Information

Active CompaniesXuzhou Medical University (Xzmu)

Inactive CompaniesN/A

Active IndicationsGraft vs Host Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A